Dr. Brian O’Connor Joins Veritas Pharma Advisory Board

VANCOUVER, British Columbia, Jan. 02, 2018 — Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt:2VP), (“Veritas” or the “Company”) is pleased to announce that Dr. Brian O’Connor, a consultant in respiratory medicine, has joined its advisory board. He is a...

Veritas Pharma Issues Incentive Stock Options

December 21, 2017, Vancouver, B.C. – Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP), (“Veritas” or the “Company”) announces the issuance of 2,350,000 stock options at $0.64 to directors, management, and consultants of the Company for a term of twelve...

The Veritas Newsletter

Enter your email to receive news alerts and updates from Veritas Pharma.

You have Successfully Subscribed!